Research Publications
Our primary focus at The Baird Institute is to encourage and fund research to improve the surgical outcomes and quality of life for patients facing heart or lung surgery. The funds we raise go directly to research that improves the surgical procedures associated with heart and lung surgery. Improvements can include less intrusive procedures as well as techniques that improve survival rates.
Below you will find a list of publications that our surgeons and research fellows have been involved in writing.
Transapical aortic valve implantation – an Australian experience
Seco M, Martinez G, Bannon PG, Cartwright BL, Adams M, Ng M, Wilson MK, Vallely MP Heart Lung Circ 2014 May;23(5):462-8 PMID: 24315653 Abstract BACKGROUND: The aim of this study was to report our initial experience with the transapical approach to transcatheter aortic valve implantation (TAVI) at an Australian institution. METHODS: All patients with severe,…
The silent and apparent neurological injury in transcatheter aortic valve implantation study (SANITY): concept, design and rationale
Fanning JP, Wesley AJ, Platts DG, Walters DL, Eeles EM, Seco M, Tronstad O, Strugnell W, Barnett AG, Clarke AJ, Bellapart J, Vallely MP, Tesar PJ, Fraser JF BMC Cardiovasc Disord 2014;14:45 PMID: 24708720 Abstract BACKGROUND: The incidence of clinically apparent stroke in transcatheter aortic valve implantation (TAVI) exceeds that of any other procedure performed…
Immobilisation of a fibrillin-1 fragment enhances the biocompatibility of PTFE
Hajian H, Wise SG, Bax DV, Kondyurin A, Waterhouse A, Dunn LL, Kielty CM, Yu Y, Weiss AS, Bilek MM, Bannon PG, Ng MK Colloids Surf B Biointerfaces 2014 Apr;116:544-52 PMID: 24572497 Abstract Current vascular biomaterials exhibit poor biocompatibility characterised by failure to promote endothelialisation, predisposition to neoinitmal hyperplasia and excessive thrombogenicity. Fibrillin-1, a major…
Standardizing clinical end points in aortic arch surgery: a consensus statement from the International Aortic Arch Surgery Study Group
Yan TD, Tian DH, Lemaire SA, Hughes GC, Chen EP, Misfeld M, Griepp RB, Kazui T, Bannon PG, Coselli JS, Elefteriades JA, Kouchoukos NT, Underwood MJ, Mathew JP, Mohr FW, Oo A, Sundt TM, Bavaria JE, Di Bartolomeo R, Di Eusanio M, Trimarchi S, Circulation 2014 Apr;129(15):1610-6 PMID: 24733540 Abstract
Detection of serious complications by MR imaging in asymptomatic young adults with repaired coarctation of the aorta
Padang R, Dennis M, Semsarian C, Bannon PG, Tanous DJ, Celermajer DS, Puranik R Heart Lung Circ 2014 Apr;23(4):332-8 PMID: 24210077 Abstract BACKGROUND: Despite early repair, patients with aortic coarctation (CoA) continue to have a reduced life expectancy due to the development of late complications. We sought to define the rate of aortic abnormalities in…
Outcomes of aortic arch replacement surgery after previous cardiac surgery
Davies RA, Black D, Bannon PG, Bayfield MS, Hendel PN, Hughes CF, Wilson MK, Vallely MP ANZ J Surg 2013 Nov;83(11):827-32 PMID: 23782742 Abstract BACKGROUND: Aortic arch replacement is a potentially high-risk operation and in the re-operative setting has been found to be a risk factor for poor outcome, yet there is a dearth of…
A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma
Cao C, Tian D, Park J, Allan J, Pataky KA, Yan TD Lung Cancer 2014 Feb;83(2):240-5 PMID: 24360321 Abstract BACKGROUND: Malignant pleural mesothelioma (MPM) is an aggressive disease of the pleural lining with a dismal prognosis. Surgical treatments of MPM with a curative intent include extrapleural pneumonectomy and extended pleurectomy/decortication (P/D). This meta-analysis aimed to…
ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma
Cheng YY, Kirschner MB, Cheng NC, Gattani S, Klebe S, Edelman JJ, Vallely MP, McCaughan BC, Jin HC, van Zandwijk N, Reid G J Thorac Oncol 2013 Oct;8(10):1317-28 PMID: 24457242 Abstract INTRODUCTION: Epigenetic inactivation of tumor suppressor genes is involved in the development of malignant pleural mesothelioma (MPM). ZIC1, a potential tumor suppressor gene involved…